MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SNDX has $529,706K in assets. $465,076K in debts. $134,930K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
439.64%
Quick Ratio
439.64%
Cash Ratio
112.33%
Debt to Asset Ratio
87.80%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty interest financing, less...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
134,930
Short-term investments
259,140
Accounts receivable, net
37,996
Inventory, net
32,754
Short-term deposits
19,616
Other receivables, net
6,404
Collaboration receivable, net
23,745
Prepaid expenses and other current assets
13,496
Total current assets
528,081
Long-term investments
0
Property and equipment, gross
606
Accumulated depreciation
425
Property and equipment, net
181
Right-of-use asset
1,342
Restricted cash
102
Total assets
529,706
Accounts payable
16,580
Collaboration payable, net
0
Accrued expenses and other current liabilities
103,064
Current portion of royalty interest financing
0
Current portion of right-of-use liability
470
Current portion of capital lease
2
Total current liabilities
120,116
Royalty interest financing, less current portion
343,909
Right-of-use liability, less current portion
1,051
Total long-term liabilities
344,960
Total liabilities
465,076
Common stock, 0.0001 par value, 200,000,000 shares authorized at december 31, 2025 and december 31, 2024, respectively 87,405,979 and 85,694,443 shares outstanding at december 31, 2025 and december 31, 2024, respectively
9
Additional paid-in capital
1,570,749
Accumulated other comprehensive income
452
Accumulated deficit
-1,506,580
Total stockholders' equity
64,630
Total liabilities and stockholders' equity
529,706
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$259,140K Cash and cashequivalents$134,930K Accounts receivable, net$37,996K Inventory, net$32,754K Collaboration receivable, net$23,745K Short-term deposits$19,616K Prepaid expenses andother current assets$13,496K Other receivables,net$6,404K Property and equipment,gross$606K Total current assets$528,081K Right-of-use asset$1,342K Property and equipment,net$181K Restricted cash$102K Accumulated depreciation$425K Total assets$529,706K Total liabilities andstockholders' equity$529,706K Total liabilities$465,076K Total stockholders'equity$64,630K Accumulated deficit-$1,506,580K Total long-termliabilities$344,960K Total currentliabilities$120,116K Additional paid-in capital$1,570,749K Accumulated othercomprehensive income$452K Common stock, 0.0001par value,...$9K Royalty interestfinancing, less current...$343,909K Right-of-use liability, lesscurrent portion$1,051K Accrued expenses andother current...$103,064K Accounts payable$16,580K Current portion ofright-of-use liability$470K Current portion ofcapital lease$2K

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (SNDX)